COMP <GO>
RXRX vs BCRX // GROSS PROFIT MARGIN
Recursion Pharmaceuticals Inc. (NASDAQ) VS. BioCryst Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: RXRX 1
— BCRX 5
■ METRIC PARITY
LAST: $3.83 (-4.96%) • MKT CAP: $2.29B
gross-margins
5.00%
LAST: $8.24 (-2.66%) • MKT CAP: $2.11B
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RXRX VS. BCRX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RXRX | BCRX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 5.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 85.00% | -120.00 | BCRX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 6.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -14.95% | 15.96% | -30.91 | BCRX | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 26.90% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.59 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | BCRX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.8 | 48.8 | -1.00 | BCRX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 7.7x | +24.30 | BCRX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.29B | $2.11B | $179.2M | RXRX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RXRX REV | BCRX REV | RXRX GROSS % | BCRX GROSS % | RXRX FCF | BCRX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $74.7M | $954.8M | 5.0% | — | -$378.3M | $347.4M |
| FY 2024 | $58.8M | $7.1M | 23.1% | — | -$372.9M | -$52.0M |
| FY 2023 | $44.6M | $290.4M | — | — | -$289.8M | -$95.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RXRX // BETA 1.00
BCRX // BETA —